ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Sulfamide → Ethyl 4-[(acetylamino)methyl]cyclohexanecarboxylate

HRID 23746
印刷

反応式

HRID 23746 の反応式
C(NCC1CCC(C[O:17][Si](C(C)(C)C)(C)C)CC1)C1C=CC=CC=1.[Si](OCC1CCC(CNCC)CC1)(C(C)(C)C)(C)C.[Si](OCC1CCC(CNC(=O)C)CC1)(C(C)(C)C)(C)C.[H-].[Al+3].[Li+].[H-].[H-].[H-].[Si](OCC1CCC(CN(CC)S(N)(=O)=O)CC1)(C(C)(C)C)(C)C.NS([N:97]([CH2:105][CH:106]1[CH2:111][CH2:110][CH:109]([C:112]([O:114][CH2:115][CH3:116])=[O:113])[CH2:108][CH2:107]1)[CH2:98][C:99]1C=CC=CC=1)(=O)=O.S(N)(N)(=O)=O>O1CCCC1.COCCOC>[C:98]([NH:97][CH2:105][CH:106]1[CH2:111][CH2:110][CH:109]([C:112]([O:114][CH2:115][CH3:116])=[O:113])[CH2:108][CH2:107]1)(=[O:17])[CH3:99]
参加物実験手順後処理出典と根拠反応ノート

参加物

10

反応物 7

HCID 82267SulfamideHCID 20757639N-{[4-({[tert-butyl(dimethyl)silyl]oxy}methyl)cyclohexyl]methyl}-N-ethylsulfamideHCID 20757664N-{[4-({[tert-butyl(dimethyl)silyl]oxy}methyl)cyclohexyl]methyl}acetamideHCID 20757665N-{[4-({[tert-butyl(dimethyl)silyl]oxy}methyl)cyclohexyl]methyl}-N-ethylamine2 回HCID 20757667N-benzyl-N-{[4-({[tert-butyl(dimethyl)silyl]oxy}methyl)cyclohexyl]methyl}amine
HCID 21226445
Aluminium lithium hydride
HCID 22574474Ethyl 4-{[(aminosulfonyl)(benzyl)amino]methyl}cyclohexanecarboxylate

生成物 1

HCID 22574486Ethyl 4-[(acetylamino)methyl]cyclohexanecarboxylate

試薬・触媒・溶媒 2

HCID 8028Tetrahydrofuran溶媒HCID 80711,2-Dimethoxyethane溶媒

実験手順

trans 4-(Aminomethyl)cyclohexane carboxylic acid ethyl ester (CAS 35879-53-9) (222 mg, 1.0 mmole, 1.0 eq) was dissolved in dichloromethane (5 mL) and triethyl amine (0.35 mL, 2.5 mmole, 2.5 eq) and acetic anhydride (143 μL, 1.50 mmole, 1.5 eq) was added. The reaction was stirred overnight and was complete in 18 hours. The reaction was diluted with dichloromethane and washed twice with dilute aqueous hydrochloric acid. The organic was dried over sodium sulfate, filtered and evaporated to give the title compound in quantitative yield. 1H NMR (500 MHz, DMSO-d6): δ 7.76 (s, 1H), 4.01 (q, 2H), 2.85 (t, 2H), 2.17 (m, 1H), 1.86 (m, 2H), 1.77 (s, 3H), 1.69 (m, 2H), 1.24 (m, 3H), 1.13 (t, 3H), 0.88 (m, 2H). N-{[4-(hydroxymethyl)cyclohexyl]methyl}acetamide (30): Ester (29) (220 mg, 0.97 mmole, 1.0 eq) was dissolved in tetrahydrofuran, then lithium aluminum hydride (81 mg, 2.14 mmole, 2.2 eq) was added and the reaction stirred. This was worked up after 90 minutes by quenching via simultaneous addition of water and 2N sodium hydroxide. The aqueous mixture was extracted with ethyl acetate to give the alcohol title compound in 87% yield. 1H NMR (500 MHz, DMSO-d6): δ 7.74 (s, 1H), 4.31 (t, 1H), 3.17 (t, 2H), 2.84 (t, 2H), 1.77 (s, 3H), 1.69 (m, 4H), 1.25 (m, 2H), 0.81 (m, 4H). N-{[4-({[tert-butyl(dimethyl)silyl]oxy}methyl)cyclohexyl]methyl}acetamide (31): Primary alcohol (30) was treated with t-butyldimethysilyl chloride and triethylamine in dichloromethane to give title compound in similar fashion to procedure used to make (1). 1H NMR (500 MHz, DMSO-d6): δ 7.74 (s, 1H), 3.35 (d, 2H), 2.84 (t, 2H), 1.77 (s, 3H), 1.68 (m, 4H), 1.28 (m, 2H), 0.84 (m, 13H), 0.00 (s, 6H). N-{[4-({[tert-butyl(dimethyl)silyl]oxy}methyl)cyclohexyl]methyl}-N-ethylamine (32): Intermediate (31) (50 mg, 168 mmole, 1.0 eq) was dissolved in tetrahydrofuran (0.5 mL) and lithium aluminum hydride (16.4 mg, 432 mmole, 2.6 eq) was added. Heated to reflux for 24 hours at which point reaction was complete. Cooled, quenched with saturated Rochelle's salt, extracted twice with ethyl acetate, dried, filtered and evaporated filtrate to give crude title compound. 1H NMR (500 MHz, DMSO-d6): δ 3.35 (d, 2H), 2.45 (m, 2H), 2.29 (d, 2H), 1.72 (m, 4H), 1.28 (m, 2H), 0.96 (t, 3H), 0.84 (m, 13H), 0.00 (s, 6H). N-{[4-({[tert-butyl(dimethyl)silyl]oxy}methyl)cyclohexyl]methyl}-N-ethylsulfamide (33): Following the procedure to make (16), (32) was treated with sulfamide and DME at reflux overnight to give the title compound. 1H NMR (500 MHz, DMSO-d6): δ 6.55 (s, 2H), 3.38 (d, 2H), 3.04 (m, 2H), 2.77 (d, 2H), 1.72 (m, 4H), 1.44 (m, 1H), 1.32 (m, 1H), 1.06 (t, 3H), 0.84 (m, 13H), 0.00 (s, 6H). N-{[4-({[tert-butyl(dimethyl)silyl]oxy}methyl)cyclohexyl]methyl}-N-ethylsulfamide (34): Following the procedure to make (17), intermediate (33) was used in place of (16) to give the title compound. 1H NMR (500 MHz, DMSO-d6): δ 8.53 (s, 2H), 8.42 (s, 1H), 3.35 (m, 4H), 3.15 (d, 2H), 1.70 (m, 4H), 1.51 (m, 1H), 1.32 (m, 1H), 1.08 (t, 3H), 0.83 (m, 13H), 0.00 (s, 6H). N′-[3,5-bis(trifluoromethyl)benzoyl]-N-ethyl-N-{[4-(hydroxymethyl)cyclohexyl]methyl}sulfamide (35): Following the procedure to make (4), intermediate (34) was substituted for (3) to give the title compound. 1H NMR (500 MHz, DMSO-d6): δ 8.43 (s, 2H), 8.09 (s, 1H), 4.28 (t, 1H), 3.15 (m, 4H), 2.91 (d, 2H), 1.74 (m, 4H), 1.43 (m, 1H), 1.24 (m, 1H), 1.02 (t, 3H), 0.78 (m, 4H). (4-{[({[3,5-bis(trifluoromethyl)benzoyl]amino}sulfonyl)(ethyl)amino]methyl}cyclohexyl)methyl phenylcarbamate (36): Alcohol (35) (11.6 mg, 24 mmole, 1.0 eq) was dissolved in dichloromethane followed by the addition of triethylamine (10 mL, 72 mmole, 3.0 eq) and phenyl isocyanate (2.8 mL, 26 mmole, 1.05 eq). Added additional triethylamine and phenylisocyanate to drive reaction to completion. Purified by silica gel chromatography to provide the title compound. 1H NMR (500 MHz, DMSO-d6): δ 12.39 (s, 1H), 9.55 (s, 1H), 8.54 (s, 2H), 8.39 (s, 1H), 7.43 (s, 2H), 7.24 (t, 2H), 6.95 (t, 1H), 3.88 (d, 2H), 3.35 (q, 2H), 3.19 (d, 2H), 1.77 (m, 4H), 1.57 (m, 2H), 1.09 (t, 3H), 0.92 (m, 4H).

後処理

  1. temperatureHeated
  2. temperatureto reflux for 24 hours at which point reaction
  3. temperatureCooled
  4. customquenched with saturated Rochelle's salt
  5. extractionextracted twice with ethyl acetate
  6. customdried
  7. filtrationfiltered
  8. customevaporated filtrate
  9. customto give crude title compound
  10. temperatureat reflux overnight

出典と根拠

ORDレコード
ord-59bc5ca3f8644e98b1a4cae8a4b0fb48
出典データセット
uspto-grants-2005_02
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US06852738B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート